← Leaderboards
Jialiang Liang
University Of Cincinnati
$1,434,328
Attributed
$2,625,655
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $692.5K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,625,655 · 2
By mechanism
R01$2,382,655 · 1
R21$243,000 · 1
Top collaborators
- Yigang Wang4 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Yigang Wang$11,973,905
- Muhammad Ashraf$27,715,813
- Jeffrey A Whitsett$39,524,201
- S Steven Potter$17,790,955
- Ying Xia$10,969,354
Others in their field
Other Emerging Leaders on “Regenerative Therapy”
- Judith A Kelleher-Andersson · Neuronascent, Inc.$7,321,514
- Hans Joerg Moebius · Athira Pharma, Inc.$6,312,103
- Charles Bernick · Athira Pharma, Inc.$6,312,103
- Nobuyuki Ishibashi · Children'S Research Institute$5,981,263
- Hae Lin Jang · University Of California Los Angeles$5,886,035
- Miao Sun · Versapeutics Inc$5,761,646
Research focus
Regenerative TherapyTranslationsInduced Pluripotent Stem CellMyocardial InfarctionTechnologyTranscription FactorFibroblastsGeneticInvestigationMolecularRegulationRepairedCardiacComplexEpigenetic ProcessCardiac RegenerationCellsGenesCardiovascular DiseasesClustered Regularly Interspaced Short Palindromic RepeatsCause Of DeathCicatrixDesignCrispr-Mediated Transcriptional Activation
Grant awards (5)
Engineering RNA biodevices for precise modulation of fibroblasts to boost cardiac reprogramming$243,000
R21 · FY2025 · HL · contact PI
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction$564,836
R01 · FY2024 · HL
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction$577,574
R01 · FY2023 · HL
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction$547,786
R01 · FY2022 · HL
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction$692,459
R01 · FY2021 · HL